The controversy over the proper standard for the admissibility of scientific evidence is an argument over the value of a jury trial compared with a bench trial or decisions by scientists. The argument has both a constitutional dimension in the provisions relating to a jury trial, compulsory process and due process, and a nonconstitutional dimension in the ordinary law of evidence. In the recent case of Daubert v. Merrell Dow Pharmaceuticals, Inc., the United States Supreme Court took a different approach, basing its decision almost entirely on an interpretation of the particular words used in Rule 702 of the Federal Rules of Evidence. Daubert holds that under the Federal Rules of Evidence, “scientific” evidence is not admissible unless it i...
On its face, Daubert v. Merrell Dow Pharmaceuticals was about as easy a case as the Supreme Court ge...
Abstract: With ‘novel’ scientific discoveries accelerating at an unrelenting pace, the need for acc...
In this essay, I will offer some thoughts on how we might reframe the issues governing the admissibi...
In reaching its recent decision in Daubert v. Merrell Dow Pharmaceuticals, Inc., the United States S...
A recent report of the President’s Council of Advisors on Science and Technology questioned the vali...
In the United States, Federal Rules of Evidence 702, the Frye and Daubert standards govern the admis...
In 1993, the Supreme Court of the United States stated that with the federal adoption of statutory r...
In Daubert v. Merrell Dow Pharmaceuticals, the United States Supreme Court replaced the general acce...
Historically, trial courts have been cautious about allowing juries to hear testimony from scientifi...
The 2000 amendments to Rule 702 sought to resolve the debate that had emerged in the courts in the 1...
The problem with expert evidence is not the inappropriateness of the Daubert approach. The narrow fo...
Read court decisions and commentaries from 100, or evenfive years ago, and you will find that expert...
Part I documents how courts have failed to faithfully apply Daubert’s criteria for scientific validi...
Most contemporary debates about scientific evidence focus on admissibility under Daubert and the Fed...
Nearly every treatment of scientific evidence begins with a faithful comparison between the Frye and...
On its face, Daubert v. Merrell Dow Pharmaceuticals was about as easy a case as the Supreme Court ge...
Abstract: With ‘novel’ scientific discoveries accelerating at an unrelenting pace, the need for acc...
In this essay, I will offer some thoughts on how we might reframe the issues governing the admissibi...
In reaching its recent decision in Daubert v. Merrell Dow Pharmaceuticals, Inc., the United States S...
A recent report of the President’s Council of Advisors on Science and Technology questioned the vali...
In the United States, Federal Rules of Evidence 702, the Frye and Daubert standards govern the admis...
In 1993, the Supreme Court of the United States stated that with the federal adoption of statutory r...
In Daubert v. Merrell Dow Pharmaceuticals, the United States Supreme Court replaced the general acce...
Historically, trial courts have been cautious about allowing juries to hear testimony from scientifi...
The 2000 amendments to Rule 702 sought to resolve the debate that had emerged in the courts in the 1...
The problem with expert evidence is not the inappropriateness of the Daubert approach. The narrow fo...
Read court decisions and commentaries from 100, or evenfive years ago, and you will find that expert...
Part I documents how courts have failed to faithfully apply Daubert’s criteria for scientific validi...
Most contemporary debates about scientific evidence focus on admissibility under Daubert and the Fed...
Nearly every treatment of scientific evidence begins with a faithful comparison between the Frye and...
On its face, Daubert v. Merrell Dow Pharmaceuticals was about as easy a case as the Supreme Court ge...
Abstract: With ‘novel’ scientific discoveries accelerating at an unrelenting pace, the need for acc...
In this essay, I will offer some thoughts on how we might reframe the issues governing the admissibi...